Get started
GILEAD SCIENCES INCGILEAD SCIENCES INCGILEAD SCIENCES INC

GILEAD SCIENCES INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

GILD chart


Full chart

Key facts today


JPMorgan has raised its price target for Gilead Sciences (GILD) to $130 from $120, while maintaining an overweight rating.
President Trump proposed tariffs on foreign-made pharmaceuticals, focusing on Ireland. Analysts noted Gilead Sciences has low exposure due to its California base and strong U.S. HIV drug sales.
Gilead Sciences' board advises shareholders to reject two proposals: one on risks tied to diversity practices for contractors, and another on including a CEO pay ratio in compensation plans.
Analyze the impactAnalyze the impact

GILD upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.72 T‬ MXN
Dividend yield (indicated)
2.93%
Price to earnings Ratio (TTM)
313.57
Basic EPS (TTM)
8.00 MXN
Net income (FY)
‪10.01 B‬ MXN
Revenue (FY)
‪598.94 B‬ MXN
Shares float
‪1.24 B‬
Beta (1Y)
0.59

Employees


Employees (FY)
‪17.6 K‬
Change (1Y)
−400 −2.22%
Revenue / Employee (1Y)
‪34.03 M‬ MXN
Net income / Employee (1Y)
‪568.62 K‬ MXN

About Gilead Sciences, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Daniel P. O'Day
Website
gilead.com
Headquarters
Foster City
Founded
1987
FIGI
BBG00JX0PJB0
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

GILD news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

GILD highest yielding bonds


GILD5050849
Gilead Sciences, Inc. 2.8% 01-OCT-2050
Yield to maturity
6.99%
Maturity date
Oct 1, 2050
US375558BS1
GILEAD SCIEN 20/40
Yield to maturity
6.47%
Maturity date
Oct 1, 2040
US375558BK8
GILEAD SCIENCES 16/47
Yield to maturity
6.25%
Maturity date
Mar 1, 2047
GILD4184058
Gilead Sciences, Inc. 4.5% 01-FEB-2045
Yield to maturity
6.04%
Maturity date
Feb 1, 2045
GISE
GILEAD SCIENCES 2046
Yield to maturity
6.00%
Maturity date
Mar 1, 2046
GILD5939386
Gilead Sciences, Inc. 5.6% 15-NOV-2064
Yield to maturity
5.83%
Maturity date
Nov 15, 2064
GILD4104362
Gilead Sciences, Inc. 4.8% 01-APR-2044
Yield to maturity
5.80%
Maturity date
Apr 1, 2044
GILD5939385
Gilead Sciences, Inc. 5.5% 15-NOV-2054
Yield to maturity
5.71%
Maturity date
Nov 15, 2054
GILD5648609
Gilead Sciences, Inc. 5.55% 15-OCT-2053
Yield to maturity
5.67%
Maturity date
Oct 15, 2053
GILD.GO
Gilead Sciences, Inc. 5.65% 01-DEC-2041
Yield to maturity
5.61%
Maturity date
Dec 1, 2041
GISG
GILEAD SCIENCES 16/36
Yield to maturity
5.59%
Maturity date
Sep 1, 2036

See all GILD bonds 

Sparks


Curated watchlists where GILD is featured.

See all sparks 


Check out other big names from the same industry as GILD.

Frequently Asked Questions


The current price of GILD is 2,153.00 MXN — it has decreased by −6.81% in the past 24 hours. Watch GILEAD SCIENCES INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange GILEAD SCIENCES INC stocks are traded under the ticker GILD.
GILD stock has fallen by −7.49% compared to the previous week, the month change is a 1.99% rise, over the last year GILEAD SCIENCES INC has showed a 74.27% increase.
We've gathered analysts' opinions on GILEAD SCIENCES INC future price: according to them, GILD price has a max estimate of 2,835.44 MXN and a min estimate of 1,822.78 MXN. Watch GILD chart and read a more detailed GILEAD SCIENCES INC stock forecast: see what analysts think of GILEAD SCIENCES INC and suggest that you do with its stocks.
GILD stock is 7.31% volatile and has beta coefficient of 0.59. Track GILEAD SCIENCES INC stock price on the chart and check out the list of the most volatile stocks — is GILEAD SCIENCES INC there?
Today GILEAD SCIENCES INC has the market capitalization of ‪2.76 T‬, it has decreased by −5.22% over the last week.
Yes, you can track GILEAD SCIENCES INC financials in yearly and quarterly reports right on TradingView.
GILEAD SCIENCES INC is going to release the next earnings report on Apr 24, 2025. Keep track of upcoming events with our Earnings Calendar.
GILD earnings for the last quarter are 39.61 MXN per share, whereas the estimation was 36.23 MXN resulting in a 9.35% surprise. The estimated earnings for the next quarter are 35.79 MXN per share. See more details about GILEAD SCIENCES INC earnings.
GILEAD SCIENCES INC revenue for the last quarter amounts to ‪157.81 B‬ MXN, despite the estimated figure of ‪149.12 B‬ MXN. In the next quarter, revenue is expected to reach ‪137.42 B‬ MXN.
GILD net income for the last quarter is ‪37.17 B‬ MXN, while the quarter before that showed ‪24.69 B‬ MXN of net income which accounts for 50.57% change. Track more GILEAD SCIENCES INC financial stats to get the full picture.
Yes, GILD dividends are paid quarterly. The last dividend per share was 15.76 MXN. As of today, Dividend Yield (TTM)% is 2.82%. Tracking GILEAD SCIENCES INC dividends might help you take more informed decisions.
GILEAD SCIENCES INC dividend yield was 3.33% in 2024, and payout ratio reached 805.23%. The year before the numbers were 3.70% and 66.62% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 27, 2025, the company has ‪17.6 K‬ employees. See our rating of the largest employees — is GILEAD SCIENCES INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. GILEAD SCIENCES INC EBITDA is ‪279.97 B‬ MXN, and current EBITDA margin is 46.74%. See more stats in GILEAD SCIENCES INC financial statements.
Like other stocks, GILD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GILEAD SCIENCES INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So GILEAD SCIENCES INC technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating GILEAD SCIENCES INC stock shows the buy signal. See more of GILEAD SCIENCES INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.